http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0914340-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_60867eeac051ca001adebb32120e016b |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-60 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-60 |
filingDate | 1997-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f88907b54328ba9466d3cea52677822 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722df9b62e3985ec780432f629173bd9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f192466e850cc3895d272c2924ae0c98 |
publicationDate | 1999-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0914340-A1 |
titleOfInvention | hGH-RH(1-29)NH 2? ANALOGUES HAVING ANTAGONISTIC ACTIVITY |
abstract | A peptide selected from the group having the formulae: alpha ) X-R1-R2-R3-R4-R5-R6-Thr-R8-R9-R10-R11-R12-Val-Leu-R15-Gln-Leu-Ser-R19-R20-R21-Leu-Leu-Gln-Asp-Ile-R27-R28-R29, wherein X is H, Ac, Aqc, IAc, BrProp, For, Ibu, Nac, 2-Nac, 1- or 2-Npt, 1- or 2-Npr, PhAc, Fpr, or any other aromatic or nonpolar acyl group, R1 is Tyr, His or Phe(Y), in which Y=H, F, Cl, Br, NO2, CH3 or OCH3, R2 is D-Arg, D-Cit, D-Har, D-Lys, D-Tic or D-Orn, R3 is Asp, D-Asp, Ala, D-Ala or Gly, R4 is Ala, Abu or Gly, R5 is Ile, Ala or Gly, R6 is Phe, Tic, Ala, Pro, Tpi, Nal or Phe(Y), in which Y=H, F, Cl, Br, NO2, NH2, CH3 or OCH3, R8 is Asn, Gln, Ser, Thr, Val, Leu, Ile, Ala, D-Ala, D-Asn, D-Gln, D-Thr, D-Leu, Abu, D-Abu, Nle, or Alb, R9 is Ser, R10 is Tyr or Phe(Y), in which Y=H, F, Cl, Br, NO2, CH3 or OCH3, R11 is Arg, D-Arg, or Cit, R12 is Lys, D-Lys, Cit, D-Cit, Orn, D-Orn, Nle or Ala, R15 is Gly, Ala, Abu or Gln, R19 is Ala or Abu, R20 is Arg, D-Arg or Cit, R21 is Lys, D-Lys, Orn or Cit, R27 is Met, Nle or Abu, R28 is Ser, Asn, Ala or Abu, R29 is Agm, Arg-NH2, Arg-OH, Cit-NH2, Cit-OH, Har-NH2 or Har-OH, and beta ) X-A1-B2-A3-R4-R5-R6-Thr-A8Ser-R10-R11-B12-Val-Leu-R15-A16-A17-Ser-R19-B20-B21-Leu-Leu-Gln-A26-Ile-R27-R28-R29, wherein a lactam bridge is formed between any one of the pairs of positions 1,2; 2,3; 8,12; 16,20; 17-21; 21,25; 25,29 or both 8,12 and 21,25 positions, and X is H, Ac, Aqc, IAc, BrProp, For, Ibu, Nac, 2-Nac, 1- or 2-Npt, 1- or 2-Npr, PhAc, Fpr, or any other aromatic or nonpolar acyl group, A is Glu, D-Glu, Gln, Asp, D-Asp, Asn, Abu, Leu, Tyr, His, Phe(Y), in which Y=H, F, cl, Br, NO2, NH2, CH3 or OCH3, Ser, Thr, Val, Ile, Ala, D-Ala, D-Asn, D-Gln, D-Thr, D-Leu, Abu, D-Abu, Nle, or Aib, B is Lys, D-Lys, Arg, D-Arg,Orn, D-Orn, or Agm; R4 is Ala, Abu or Gly, R5 is Ile, Ala or Gly, R6 is Phe, Tic, Tpi, Nal or Phe(Y), in which Y=H, F, Cl, Br, NO2, NH2CH3 or OCH3, R10 is Tyr or Phe(Y), in which Y=H, F, Cl, Br, NO2, NH2CH3 or OCH3, R15 is Gly, Ala, Abu or Gin, R27 is Met, Nle or Abu, R28 is Ser, Asn, Asp, Ala or Abu, and pharmaceutically acceptable salts thereof. |
priorityDate | 1996-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 361.